Pharmaceuticals
-
Row over statins for over 75s
Experts have challenged an observational study which rejects the widespread use of statins in patients over the age of 75. Read more
-
Prostate cancer sub-group may benefit from immunotherapy
Scientists have identified a one sub-group of aggressive prostate cancer patients that may benefit particularly well from immunotherapy. Read more
-
Brain implant to halt seizures
An electronic device that delivers drugs within the brain may be able to stop or even prevent seizures in people with epilepsy, researchers reported last night. Read more
-
Big data to aid cancer drug selection
Two major projects will harness the power of big data to significantly improve the choice of drugs for individual cancer patients, British researchers announced today. Read more
-
Drug combination hope for resistant cancer
A specific drug combination may have significant benefits for treatment-resistant patients with ovarian or lung cancer, British researchers announced today. Read more
-
New guidance for drug-resistant TB care
Patients with multi-drug resistant TB should be treated with oral medicines, according to new global guidance. Read more
-
Glioblastoma hope from Leeds tests
British scientists have identified a promising chemical treatment for aggressive brain tumours, it has been announced. Read more
-
Possible liver failure prevention drug unveiled
A promising new treatment has been found for sudden liver failure, according to research reported last night. Read more
-
Large ADHD drug study released
An expert analysis, published today, sets out the optimum medications for attention-deficit hyperactivity disorder (ADHD) for different age groups. Read more
-
Personalised medicine to help type 2 diabetes patients
A precision medicine approach to treating people with type 2 diabetes can help to improve blood sugar levels and avoid damaging side-effects, according to new research. Read more
